Dr. Prakash R Dhadphale, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Dr. Donna J Boyd, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Amanda Rose Moraska Benson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 |
Dr. Matthew M Supron, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Dr. Mark A Washnock, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Dr. Greg J Ghiardi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Dr. Mackenzie A Kuhl, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-225-3595 |
Maureen Mcneely, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 710 Chippewa Sq, Suite 103, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Jamie Marie Pendy, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 |
Dr. Mark L Callaghan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-2569 |
Dr. Anup K Patel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 580 W College Ave, Marquette, MI 49855 Phone: 906-226-2569 Fax: 906-226-3225 |
Dr. Brian Christopher Turner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 |
News Archive
The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.
› Verified 5 days ago